Novo Nordisk A/S (NVO)

Novo Nordisk A/S (NVO) is a Drug Manufacturers - General company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $172B; returns 1 day -1.0%, 1 week +0.6%, 1 year -26.6%.

Novo Nordisk A/S is a Danish multinational pharmaceutical company renowned for its leadership in diabetes and obesity care, which collectively represent the vast majority of its revenue (approximately 94.08% in Q3 2025).

Groups NVO belongs to

• Dividend Payers
• 25-Year Dividend Payers
• Pharmaceuticals
• Metabolic Disorders
• GLP-1 Agonists
• Healthcare
• Weight Management
• Biotechnology
• Type 1 Diabetes
• Rare Diseases
• NASH
• Biopharmaceutical

NVO financial model: income statement, cash flow and balance sheet